Hong Kong Pharma Digital Technology Holdings Limited
HKPD · NASDAQ
3/31/2025 | 9/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -16.8% | 14.6% | 38.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 5.5% | 17.2% | 23% | 19.1% |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -8.6% | 9.6% | 14.1% | 5.3% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -9.3% | 7.5% | 11.2% | 3.6% |
| EPS Diluted | -0.083 | 0.083 | 0.108 | 0.036 |
| % Growth | -199.8% | -23.3% | 200% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |